Literature DB >> 20139758

Dermatofibrosarcoma protuberans of the vulva: a clinicopathologic and immunohistochemical study of 13 cases.

Marcia Edelweiss1, Anais Malpica.   

Abstract

Dermatofibrosarcoma protuberans (DFSP) is a low-grade sarcoma seldom seen in the vulva with only 29 cases reported. We present the clinicopathologic and immunohistochemical features of 13 such cases seen in our institution over a period of 29 years (1978 to 2007). Patient age ranged from 23 to 76 years (mean, 46 y). Twelve patients had a vulvar mass. One patient presented with a pigmented skin lesion. Tumor size ranged from 1.2 to 15 cm (median, 4 cm). Microscopically, all the cases showed typical features of DFSP. In 1 case, myxoid changes were also noted; 3 cases showed fibrosarcomatous transformation. Of interest, in 7 of our 13 cases, a variety of diagnoses, such as cellular dermatofibroma, cellular leiomyoma, neurofibroma, low-grade leiomyosarcoma, fibrosarcoma, low-grade malignant schwannoma, desmoplastic melanoma, cellular neurofibroma, and low-grade malignant peripheral nerve sheet tumor were initially considered. All 11 cases tested for CD34 were positive, whereas 7/9 cases, 8/9 cases, and 9/9 cases were positive for PDGFR-alpha, PDGFR-beta, and c-abl, respectively. All patients were initially treated with excisional biopsy, wide local excision, or radical vulvectomy. Local recurrences occurred in 7 cases. One patient also developed distant metastases. All recurrences were treated surgically; 1 patient also received chemotherapy and radiotherapy and another received imatinib (Gleevec). Follow-up data ranging from 2 to 444 months was available for all patients. Nine patients had no evidence of disease, 2 patients were alive with disease, 1 patient had died of disease, and 1 patient had died of other causes. DFSP affects women of a wide age range and has a propensity to recur locally. The frequent expression of PDGFR-alpha, PDGFR-beta, and c-abl in these cases agrees with the findings of other investigators and supports the use of imatinib (Gleevec) in cases that are recurrent or not amenable to surgery.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20139758     DOI: 10.1097/PAS.0b013e3181cf7fc1

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  7 in total

1.  PDGFB Rearrangements in Dermatofibrosarcoma Protuberans of the Vulva: A Study of 11 Cases Including Myxoid and Fibrosarcomatous Variants.

Authors:  Khadijeh Jahanseir; Deyin Xing; Patricia T Greipp; William R Sukov; Gary L Keeney; Brooke E Howitt; J Kenneth Schoolmeester
Journal:  Int J Gynecol Pathol       Date:  2018-11       Impact factor: 2.762

2.  Criteria for Risk Stratification of Vulvar and Vaginal Smooth Muscle Tumors: An Evaluation of 71 Cases Comparing Proposed Classification Systems.

Authors:  Sadia Sayeed; Deyin Xing; Sarah M Jenkins; Paul S Weisman; Darya Buehler; Laura Warmke; Cora Uram-Tuculescu; Jamie N Bakkum-Gamez; Brooke E Howitt; Cherise Cortese; Kay J Park; J Kenneth Schoolmeester
Journal:  Am J Surg Pathol       Date:  2018-01       Impact factor: 6.394

3.  A Tete - a - tete of benign, borderline and malignant fibrohistiocytic tumor.

Authors:  Rashmi M V; Pavithra P; Shivakumarappa G M
Journal:  Iran J Pathol       Date:  2016

4.  Neoadjuvant treatment of Dermatofibrosarcoma Protuberans of pancreas with Imatinib: case report and systematic review of literature.

Authors:  Mashaal Dhir; David G Crockett; Todd M Stevens; Peter T Silberstein; William J Hunter; Jason M Foster
Journal:  Clin Sarcoma Res       Date:  2014-08-06

Review 5.  Review of the pathophysiology, diagnosis, and therapy of vulvar leiomyoma, a rare gynecological tumor.

Authors:  Chao Sun; Junkai Zou; Qing Wang; Qi Wang; Lu Han; Nasra Batchu; Qurat Ulain; Jiang Du; Shulan Lv; Qing Song; Qiling Li
Journal:  J Int Med Res       Date:  2017-09-06       Impact factor: 1.671

6.  Dermatofibrosarcoma protuberans: A rare and devastating tumor of the vulva.

Authors:  Robert Neff; Robert Collins; Floor Backes
Journal:  Gynecol Oncol Rep       Date:  2019-01-25

Review 7.  Cutaneous soft tissue sarcomas: survival-related factors.

Authors:  Areti Gkantaifi; Alexandros Diamantis; Davide Mauri; Ioanna Nixon; Anastassios Kyriazoglou; Ioannis Baloyiannis; Nikolaos Tsoukalas; Nikolaos Charalampakis; Dimitrios Schizas; Francesco Cuccia; Filippo Alongi; Ramon Andrade de Mello; George Iliadis; Konstantinos Kamposioras; Michalis Mazonakis; Maria Tolia
Journal:  Arch Dermatol Res       Date:  2021-07-17       Impact factor: 3.033

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.